Scholastic Corp: Form 10-Q for the period ended Feb 28, 2026
Filed with the SEC on Mar 20, 2026 and accepted by EDGAR at Mar 20, 2026, 16:11 ET.
Management's discussion and analysis
As filed, 1,922 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following table provides information with respect to repurchases of shares of Common Stock by the Corporation during the three months ended February 28, 2026:
Issuer Purchases of Equity Securities
(Dollars in millions, except per share amounts)
| Period | Total number of shares purchased | Average price paid per share | Total number of shares purchased as part of publicly announced plans or programs | Maximum number of shares (or approximate dollar value) that may yet be purchased under the plans or programs (i) |
|---|---|---|---|---|
| December 1, 2025 through December 31, 2025 | 593,121 | $29.61 | 593,121 | $132.4 |
| January 1, 2026 through January 31, 2026 | 2,259,906 | $33.66 | 2,259,906 | $56.3 |
| February 1, 2026 through February 28, 2026 | 1,086,550 | $33.87 | 1,086,550 | $19.5 |
| Total | 3,939,577 | 3,939,577 | $19.5 |
(i) Represents the amount remaining at February 28, 2026 under the Board authorization for Common share repurchases announced on December 17, 2025, which is available for further repurchases, from time to time as conditions allow, on the open market or through privately negotiated transactions. See Note 14 of Notes to Condensed Consolidated Financial Statements - unaudited in Item 1, “Financial Statements,” for a description of the Company’s share buy-back program and share repurchase authorizations. Subsequent to February 28, 2026, the Board authorized an increase of $297.0 million for common stock repurchases, resulting in a current Board authorization of $300.0 million, which includes the remaining amount from the previous Board authorization, less repurchases of $16.5 million made subsequent to February 28, 2026. See Note 20, "Subsequent Events," of Notes to the Financial Statements - Unaudited in Item 1, "Financial Statements," for more information regarding the increased authorization.
SCHOLASTIC CORPORATION
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-02-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-12-01 to 2026-02-28 | $329.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2025-06-01 to 2026-02-28 | $1.11bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-12-01 to 2026-02-28 | $150.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2025-06-01 to 2026-02-28 | $499.4m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2025-12-01 to 2026-02-28 | $192.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2025-06-01 to 2026-02-28 | $587.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-12-01 to 2026-02-28 | −$26.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-06-01 to 2026-02-28 | −$36.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-12-01 to 2026-02-28 | $29.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-06-01 to 2026-02-28 | $23.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-12-01 to 2026-02-28 | $62.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-06-01 to 2026-02-28 | $47.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-12-01 to 2026-02-28 | $2.55 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-06-01 to 2026-02-28 | $1.87 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-12-01 to 2026-02-28 | $2.61 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-06-01 to 2026-02-28 | $1.91 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-12-01 to 2026-02-28 | 24,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-06-01 to 2026-02-28 | 25,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-06-01 to 2026-02-28 | −$39.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 9 months2025-06-01 to 2026-02-28 | $15.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2025-06-01 to 2026-02-28 | $127.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2026-02-28 | $104.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-02-28 | $735.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2026-02-28 | $1.78bn | us-gaap:Assets |
| Current liabilities | At period end2026-02-28 | $621.1m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2026-02-28 | $0 | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2026-02-28 | $871.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000866729-26-000011. Last ingested by Listed: Oct 27, 2026, 17:32 ET. Listed shows no prices and gives no investment advice.